1. Home
  2. ROIV vs CINF Comparison

ROIV vs CINF Comparison

Compare ROIV & CINF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

N/A

Current Price

$35.43

Market Cap

28.7B

Sector

Health Care

ML Signal

N/A

Logo Cincinnati Financial Corporation

CINF

Cincinnati Financial Corporation

N/A

Current Price

$163.80

Market Cap

26.4B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ROIV
CINF
Founded
2014
1950
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Property-Casualty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
28.7B
26.4B
IPO Year
2021
1994

Fundamental Metrics

Financial Performance
Metric
ROIV
CINF
Price
$35.43
$163.80
Analyst Decision
Strong Buy
Hold
Analyst Count
13
8
Target Price
$48.08
★ $191.00
AVG Volume (30 Days)
★ 6.0M
519.3K
Earning Date
11-09-2026
10-26-2026
Dividend Yield
N/A
★ 2.27%
EPS Growth
N/A
★ 4.40
EPS
N/A
★ 9.78
Revenue
$8,260,000.00
★ $12,631,000,000.00
Revenue This Year
$530.75
$4.72
Revenue Next Year
$685.92
N/A
P/E Ratio
★ N/A
$16.90
Revenue Growth
N/A
★ 11.41
52 Week Low
$15.99
$150.00
52 Week High
$42.50
$194.81

Technical Indicators

Market Signals
Indicator
ROIV
CINF
Relative Strength Index (RSI) 43.66 44.12
Support Level $33.15 $159.41
Resistance Level $35.70 $165.96
Average True Range (ATR) 1.14 2.49
MACD -0.34 0.38
Stochastic Oscillator 35.90 52.40

Price Performance

Historical Comparison
ROIV
CINF

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

About CINF Cincinnati Financial Corporation

Cincinnati Financial Corp is a property and casualty insurance company that generates income through written premiums. A select group of independent agencies actively markets the company's business, home, and automotive insurance within their communities. These agents offer the company's personal lines as well as its standard market, excess, and surplus commercial line policies in many regions in the United States. Cincinnati Financial also offers leasing and financing services. The company operates in segments: Commercial lines insurance, Personal lines insurance, Excess and surplus lines insurance, Life insurance, and Investments. The vast majority of the company's revenue is generated through commercial lines, followed by personal lines.

Share on Social Networks: